A systematic review of cognitive and behavioral treatments for individuals with psoriasis

Sijercic, Iris; Ennis, Naomi; Monson, Candice M.

doi:10.1080/09546634.2019.1690625

Cited by 11 publications

(11 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Paro may be less effective for those who are already psychologically adaptive. The meta-analysis also found that effect sizes were larger for those with more severe psoriasis ( Sijercic et al, 2020 ). The patients in the current study had PASI scores ranging from very mild to very severe; however, many only had mild psoriasis, as is common in the wider community.…”

Section: Discussionmentioning

confidence: 88%

“…Research has demonstrated that psychological interventions may be more beneficial for certain patients. For example, a recent meta-analysis demonstrated that effect sizes from cognitive-behavioural interventions for patients with psoriasis were highest in those patients with higher psychopathology pre-treatment ( Sijercic et al, 2020 ). The current sample had a wide range of depression and stress scores.…”

Section: Discussionmentioning

confidence: 99%

“…Psychotherapeutic treatments to reduce stress may be beneficial for clinical outcomes and quality of life. Many studies have shown promising results, including positive results for: psychotherapy, which included relaxation training, cognitive-behavioural stress management, and symptom control imagery training ( Price et al, 1991 ; Zachariae et al, 1996 ), cognitive behavioural therapy ( Fortune et al, 2002 ; Piaserico et al, 2016 ; Sijercic et al, 2020 ), hypnosis ( Tausk and Whitmore, 1999 ), emotional disclosure ( Vedhara et al, 2007 ; Paradisi et al, 2010 ), mindfulness based cognitive therapy ( Fordham et al, 2015 ; Maddock et al, 2019 ), relaxation ( Neerackal et al, 2020 ), and mindfulness meditation ( Kabat-Zinn et al, 1998 ). A meta-analysis showed that overall, psychological interventions had a medium effect on the reduction in psoriasis severity ( Lavda et al, 2012 ).…”

Section: Introductionmentioning

confidence: 99%

“…A meta-analysis showed that overall, psychological interventions had a medium effect on the reduction in psoriasis severity ( Lavda et al, 2012 ). Further evidence demonstrates that these interventions may be particularly effective for those with high levels of stress and more severe psychiatric diagnoses ( Sijercic et al, 2020 ). Even if psychological interventions do not directly affect psoriasis severity, they can have substantial impacts on patients’ quality of life and psychological health ( O'Leary et al, 2004 ; Zill et al, 2019 ).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

The Effects of Interacting With a Paro Robot After a Stressor in Patients With Psoriasis: A Randomised Pilot Study

et al. 2022

View full text Add to dashboard Cite

ObjectiveStress can play a role in the onset and exacerbation of psoriasis. Psychological interventions to reduce stress have been shown to improve psychological and psoriasis-related outcomes. This pilot randomised study investigated the feasibility of a brief interaction with a Paro robot to reduce stress and improve skin parameters, after a stressor, in patients with psoriasis.MethodsAround 25 patients with psoriasis participated in a laboratory stress task, before being randomised to either interact with a Paro robot or sit quietly (control condition) for 30 min. Raman spectroscopy and trans-epidermal water loss were measured at baseline, after the stressor and after the intervention as indexes of acute skin changes. Psychological variables, including self-reported stress and affect, were also measured at the three time-points.ResultsNo statistically significant differences between the two conditions were found for any of the outcomes measured. However, effect sizes suggest significance could be possible with a larger sample size. Changes in the psychological and Raman spectroscopy outcomes across the experimental session were found, indicating the feasibility of the procedures.ConclusionThis pilot study showed that a brief interaction with a Paro robot was a feasible intervention for patients with psoriasis, but future trials should broaden the inclusion criteria to try to increase recruitment rates. Studying people who are highly stressed, depressed or who are stress-responders may increase the power of the intervention to show effects using a longer-term intervention.

show abstract

Section: Discussionmentioning

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Effects of Interacting With a Paro Robot After a Stressor in Patients With Psoriasis: A Randomised Pilot Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Thus while there is some diversity in approaches, psychological interventions built around a clinician-led cognitive-behavioural model of functioning alongside medical management have been shown to most consistently have merit in people with psoriasis. [12][13][14][15] In addition there is also recent evidence of the utility of third wave approaches, in particular mindfulness and acceptancebased or compassion focussed approaches which involve developing a more compassionate style of self-to-self relating. [16][17][18] Hover, a substantial proportion of patients who could benefit may not attend clinics due to the very issues that such adjunctive programmes are designed to target (e.g., embarrassment, stigma).…”

Section: Introductionmentioning

confidence: 99%

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

Fortune

Ravnkilde

Ryan

et al. 2022

Skin Health and Disease

View full text Add to dashboard Cite

Background Despite the psychosocial challenges of living with psoriasis many patients may not be able to access appropriate services to manage these challenges. Mobile health interventions may be helpful as a means to support patients in managing the impact of their condition. Objective To conduct a preliminary examination of the feasibility and acceptability of a bespoke psoriasis‐specific digital therapeutic solution (hereafter termed Allay ), and to provide initial data on psychological changes pre‐post. Methods Phase one proof of concept pre‐post study. Eligible patients were provided with Allay on their smartphone and assessed at baseline and at 12 weeks on a range of indices of well‐being. Participants experiences on usability were collected by telephone interview at 4 weeks, 8 and 12 weeks. Results Out of 66 participants recruited, 59 persisted in using Allay after the familiarisation phase, and 34 participants completed the 12 weeks programme. Participants showed a statistically significant improvement between induction and the end of the 12 weeks programme on Quality of life, Resilience, Perceptions of ‘Overall impact’ of psoriasis, and ‘Emotional impact’. There was a significant change over the course of using Allay for symptoms of depression but not anxiety. While there was an interaction effect of changes in severity of psoriasis symptoms over the course of the study for dermatology‐specific measures, there was no interaction between such changes in psoriasis symptoms and changes in depression, resilience or beliefs in emotional impact. Conclusions Study results suggest that the use of Allay as an adjunct to medical management of psoriasis may help patients improve resilience, mood, beliefs about their condition and enhance their quality of life. Given that this is a phase one proof of concept study, and our rates of attrition further research is necessary to examine comparative effectiveness and stability of these findings.

show abstract

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Berk,

Köhler‐Forsberg,

Turner

et al. 2023

World Psychiatry

View full text Add to dashboard Cite

Populations with common physical diseases – such as cardiovascular diseases, cancer and neurodegenerative disorders – experience substantially higher rates of major depressive disorder (MDD) than the general population. On the other hand, people living with MDD have a greater risk for many physical diseases. This high level of comorbidity is associated with worse outcomes, reduced adherence to treatment, increased mortality, and greater health care utilization and costs. Comorbidity can also result in a range of clinical challenges, such as a more complicated therapeutic alliance, issues pertaining to adaptive health behaviors, drug‐drug interactions and adverse events induced by medications used for physical and mental disorders. Potential explanations for the high prevalence of the above comorbidity involve shared genetic and biological pathways. These latter include inflammation, the gut microbiome, mitochondrial function and energy metabolism, hypothalamic‐pituitary‐adrenal axis dysregulation, and brain structure and function. Furthermore, MDD and physical diseases have in common several antecedents related to social factors (e.g., socioeconomic status), lifestyle variables (e.g., physical activity, diet, sleep), and stressful live events (e.g., childhood trauma). Pharmacotherapies and psychotherapies are effective treatments for comorbid MDD, and the introduction of lifestyle interventions as well as collaborative care models and digital technologies provide promising strategies for improving management. This paper aims to provide a detailed overview of the epidemiology of the comorbidity of MDD and specific physical diseases, including prevalence and bidirectional risk; of shared biological pathways potentially implicated in the pathogenesis of MDD and common physical diseases; of socio‐environmental factors that serve as both shared risk and protective factors; and of management of MDD and physical diseases, including prevention and treatment. We conclude with future directions and emerging research related to optimal care of people with comorbid MDD and physical diseases.

show abstract

A systematic review of cognitive and behavioral treatments for individuals with psoriasis

Cited by 11 publications

References 25 publications

The Effects of Interacting With a Paro Robot After a Stressor in Patients With Psoriasis: A Randomised Pilot Study

The Effects of Interacting With a Paro Robot After a Stressor in Patients With Psoriasis: A Randomised Pilot Study

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Contact Info

Product

Resources

About